The constant increase in the number of immunocompromised patients or with other risk factors for mycosis and the use of antifungals as prophylaxis, have led to the increase, increasingly frequent, of invasive infections caused by atypical yeasts, within which there are species with natural or acquired resistance to antifungal drugs. Additionally, some of these yeasts cause infections associated with health care and have significant morbidity and mortality rates. This study aims to characterize the atypical yeast species recovered at the Hospital Universitario Mayor Méderi, through molecular identification, antifungal susceptibility profile and epidemiological characteristics of infected patients.
Short title | Characterization of rare yeasts |
---|
Status | Active |
---|
Effective start/end date | 17/12/21 → 5/03/25 |
---|
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):